オーダーセンター

オーダーセンターはこちらから

日本語SDS

日本語SDSをカタログ番号からご検索いただけます。

カスタムオリゴのオーダー

カスタム(シグマジェノシス)製品。カスタムオリゴDNA, カスタムペプチド、カスタムポリクローナル抗体作製、カスタムsiRNA、プレデザインsiRNAなどを国内の合成拠点から迅速にお届けいたします。

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

お問い合わせ先一覧

Contact Customer Service

カタログ請求

Request literature from Sigma-Aldrich

化合物検索

アルドリッチの約20万物質を部分構造式や用途・反応タイプ別に検索できます。

キャンペーン

お得なキャンペーン情報はこちら

SAFCの原料・バルク・受託合成

カタログ掲載製品の原料・バルク供給、および各種化学品の受託合成を承ります。

News & Information

St. Louis, MO - January 22, 2014 Sigma-Aldrich® Named to "Global 100 Most Sustainable Corporations in the World" List

Sigma-Aldrich Corporation (NASDAQ: SIAL) was named today for the first time to the "Global 100 Most Sustainable Corporations in the World" list in an announcement made earlier at the World Economic Forum in Davos, Switzerland. The St. Louis-based Company was ranked 20th, one of the highest rankings among its peers.

Read More
St. Louis, MO - January 21, 2014 Sigma-Aldrich® Signs Agreement with Goodfellow Cambridge, Ltd., to Distribute Metals, Alloys and Ceramics to Researchers Worldwide

Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, today announced the signing of an agreement with Goodfellow Cambridge, Ltd., a leading international supplier of metals and materials for research and industry, to market and distribute Goodfellow's portfolio of materials which includes metals, alloys and ceramics. The agreement expands the availability of Goodfellow's products to new regions worldwide through the Aldrich® Materials Science initiative.

Read More
Japan - January 17, 2014 Sigma® Life Science Launching Genetically-Modified HepaRG™ Human Liver Cells Licensed from Biopredic for Cell-based ADME/Tox Assays

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that Sigma® Life Science, its innovative biological products and services business, will be launching the genetically-modified HepaRG human liver cell line, licensed from Biopredic, for hepatotoxicity and drug metabolism assays. Currently undergoing beta-testing by multiple contract research and pharmaceutical organizations, the assays will be publicly available later in Q1 2014 in a plated, live-cell format to support translational research in industry and academia. Through this license agreement with BioPredic International, Sigma-Aldrich will also offer high-quality wild-type HepaRG liver cells and supporting media.

Read more
Japan - March 25, 2014 新着情報

2014.03.25,[キャンペーン],
カスタム製品新規会員登録キャンペーン(742KB PDF)

2014.03.25,[キャンペーン],
4月のお買い得品キャンペーン(339KB PDF)

 

 

Read More